Increased AKT3 enzymatic activity was found in estrogen receptor-deficient breast cancer and androgen insensitive prostate cancer cell lines, suggesting that AKT3 may contribute to the aggressiveness of steroid hormone-insensitive cancers [3]. Here, AKT3 is linked to prostate carcinoma.